Publication | Closed Access

Nanoparticles assembled from fucoidan and trimethylchitosan as anthrax vaccine adjuvant: In vitro and in vivo efficacy in comparison to CpG

VaccinationNanomedicineCross-protectionNanoparticlesEngineeringTherapeutic VaccineAnthrax Vaccine AdjuvantVivo EfficacyNano-drug DeliveryBiomedical EngineeringMedicine